| 标题 |
Perioperative atezolizumab plus chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC
|
| 备注 |
暂无具体链接
💡 该求助存在备注,如果存在信息冲突,请以备注为准
|
| 网址 |
求助人暂未提供
|
| DOI |
暂未提供,该求助的时间将会延长,查看原因?
|
| 其它 | Perioperative atezolizumab plus chemotherapy more than doubles event-free survival in resectable stage II–IIIB NSCLC. News release. International Association for the Study of Lung Cancer. September 12, 2026. Accessed September 13, 2026. |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)